TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
Voltar para busca
Dado oficial do USPTO
BIOCON BIOLOGICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 16, 42
Data de depósito
22/12/2022
Data de registro
24/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/09/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
IN
Examinador
BRADLEY, EVELYN
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "BIOCON BIOLOGICS" with a design of two bands comprised of shorter bands attached to circles.
Titulares e representantes
Titulares
Biocon Biologics Limited
Representantes
Martin Schwimmer STOBBS
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 16Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industryscience and photography; chemicals for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hidestanning agents for use in the manufacture of leather; Adhesives for use in industry; oil cement putty; paste fillers for automotive body repairs; compost; manures; fertilizers; biological preparations for use in industry and science
Classe 5
Pharmaceuticals and medical preparations used in the field of diabetologyoncologynephrologyendocrinologyimmunology specifically for the treatment of autoimmune diseasesEndocrine disorders and diseasesrenal disorderdiabetes and cancer; pharmaceutical and medical preparations for treatment of metabolic disorders; Pharmaceutical preparations used in treatment of diabetescancerrenal disorderheart diseasesautoimmune diseasesbacterial and viral infections
Classe 10
Surgicalmedical apparatusdevices and instrumentsinjectors for medical purposesneedles for medical purposesInsulin pens sold empty; Injection needles; Hypodermic needles; Medicinal injection syringes; Injection device for pharmaceuticals; Injection instruments without needles; Automatic medical apparatus for dosing humans by injection
Classe 16
Paper and paper articlespaper foldersprinting paper; paper banner; cardboard and cardboard articles in the nature of cardboard boxes; printed matter in the nature of printed greeting cards; printed calendars; printed desk calendarsprinted publications in the nature of magazines in the field of pharmacy and medicine; stationery; adhesive materials for office use; typewriters; office requisitesrubber stamps; envelopes; document files; printed diaries; bags of paper for packaging; printed name cards; printed leaflets about pharmacy and medicine; printed instructional and teaching materials in the field of pharmaceuticals; printed leaflets featuring information about pharmaceuticals
Classe 42
Pharmaceutical research and development; medical and scientific research services in the field of cancer treatment and diagnosiscardiologynephrologyendocrinology; chemicalbiochemicalbiological and bacteriological research and analysis
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/03/2025
FIMP
FINAL DISPOSITION PROCESSED
28/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2024
PUBO
PUBLISHED FOR OPPOSITION
09/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/02/2024
GNRT
NON-FINAL ACTION E-MAILED
29/02/2024
CNRT
NON-FINAL ACTION WRITTEN
29/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/02/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/02/2024
RFNT
REFUSAL PROCESSED BY IB
07/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/10/2023
RFRR
REFUSAL PROCESSED BY MPU
17/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/09/2023
CNRT
NON-FINAL ACTION WRITTEN
29/09/2023
DOCK
ASSIGNED TO EXAMINER
23/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
16/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/06/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOCON BIOLOGICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.